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Purified retroviruses, their recombinant transmembrane
envelope (TM) proteins and synthetic peptides corre-
sponding to a highly conserved so-called immunosup-
pressive (isu-) domain of the TM protein have been
shown to inhibit mitogen-triggered lymphocyte prolifera-
tion. The TM protein gp41 and the isu-peptide of HIV-1
have been shown to increase the expression of IL-6, IL-8,
IL-10, RANTES, MCP-1, MCP-2, GRO-alpha, TNF-alpha,
MIP-1alpha, MIP-1beta, MIP-3 and to decrease the expres-
sion of IL-2. Extending these studies we showed that puri-
fied Koala retrovirus (an endogenous retrovirus inducing
immunodeficiencies in its host) and the TM protein of the
human endogenous retrovirus HERV-K (which is highly
expressed in human melanomas and teratocarcinomas)
also inhibited lymphocyte proliferation and showed the
same results in cytokine arrays. Furthermore, we showed
for the first time that the TM protein of HERV-K and the
isu-peptide of HIV-1 were able to induce CD4+CD25+
Treg cells with an increased expression of FoxP3. These
data correlate with findings showing elevated IL-6, IL-10,
IL-8, GRO-alpha, TNF-alpha and decreased IL-2 values as
well as increased numbers of Treg in HIV infected individ-
uals and suggest that the TM proteins may play an impor-
tant role in retrovirus-induced immunopathogenesis.
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